Table 2 PCI versus medical therapy in baseline characteristics
Medical therapy group (n = 1018) | PCI group (n = 1346) | P value | |
|---|---|---|---|
Age in years | 65.6 ± 9.6 | 64.4 ± 10.0 | < 0.05 |
Male, n (%) | 562 (55.2) | 870 (64.6) | < 0.001 |
History of smoking, n (%) | 442 (43.4) | 698 (51.9) | < 0.001 |
Hypertension, n (%) | 769 (75.5) | 1004 (74.6) | 0.598 |
Diabetes mellitus, n (%) | 368 (36.1) | 573 (42.6) | < 0.05 |
Family history of CHD, n (%) | 270 (26.5) | 355 (26.4) | 0.936 |
Previous MI, n (%) | 65 (6.4) | 125 (9.3) | < 0.05 |
Atrial fibrillation, n (%) | 73 (7.2) | 55 (4.1) | < 0.05 |
Chronic kidney disease, n (%) | 114 (11.2) | 149 (11.1) | 0.992 |
Prior stroke, n (%) | 153 (15.0) | 230 (17.1) | 0.179 |
PAD, n (%) | 77 (7.6) | 113 (8.4) | 0.462 |
Heart failure, n (%) | 55 (5.4) | 78 (5.8) | 0.682 |
LVEF (%) | 67 ± 7 | 66 ± 8 | < 0.05 |
Heart rate (bpm) | 70.6 ± 11.2 | 70.8 ± 11.6 | 0.663 |
BMI (kg/m2) | 25.84 ± 3.57 | 25.92 ± 3.47 | 0.577 |
FPG (mmol/L) | 7.85 ± 3.18 | 8.38 ± 3.94 | < 0.05 |
Triglyceride (mmol/L) | 1.56 ± 1.16 | 1.68 ± 1.09 | < 0.05 |
Total cholesterol (mmol/L) | 4.27 ± 0.96 | 4.37 ± 1.11 | < 0.05 |
HDL-C (mmol/L) | 1.17 ± 0.27 | 1.12 ± 0.27 | < 0.001 |
LDL-C (mmol/L) | 2.39 ± 0.70 | 2.49 ± 0.79 | < 0.05 |
Serum uric acid (umol/L) | 335 ± 85 | 345 ± 82 | < 0.05 |
hs-CRP (mg/L) | 3.41 ± 5.78 | 3.67 ± 5.94 | 0.277 |
SYNTAX score | 12.90 ± 9.33 | 21.04 ± 10.16 | < 0.001 |
Low SYNTAX score, n (%) | 889 (87.3) | 806 (59.9) | < 0.001 |
Medium SYNTAX score, n (%) | 81 (8.0) | 351 (26.1) | |
High SYNTAX score, n (%) | 48 (4.7) | 189 (14.0) |